ALBANY, N.Y., Aug. 30, 2016 /PRNewswire/ -- Albany Molecular
Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief
Executive Officer, will present at the Morgan Stanley Global
Healthcare Conference on Tuesday, September
13, 2016 at 3:30 p.m. ET. A
live audio webcast of the presentation can be accessed at AMRI's
Investor Relations web site at
http://ir.amriglobal.com/events.cfm?CalendarID=2.
The webcast will be archived for 90 days following the live
presentation.
About AMRI
Albany Molecular Research Inc. (AMRI)
is a global contract research and manufacturing organization that
has been working with the Life Sciences industry to improve patient
outcomes and the quality of life for more than two decades. With
locations in North America, Europe and Asia,
our key business segments include Discovery and Development
Services (DDS), Active Pharmaceutical Ingredients (API), Drug
Product Manufacturing (DPM), and Fine Chemicals. Our DDS segment
provides comprehensive services from hit identification to IND,
including expertise with diverse chemistry, library design and
synthesis, in vitro biology and pharmacology, drug metabolism and
pharmacokinetics, as well as natural products. API supports the
chemical development and cGMP manufacture of complex API, including
potent and cytotoxic compounds, controlled substances, steroids,
hormones, and sterile API. DPM supports development through
commercial scale production of complex liquid-filled and
lyophilized parenterals, sterile suspensions and ophthalmic
formulations. For more information about AMRI, please visit our
website at www.amriglobal.com or follow us on Twitter
(@amriglobal).
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/amri-ceo-to-present-at-morgan-stanley-global-healthcare-conference-300319352.html
SOURCE AMRI